Cargando…

An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021

An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) spread from one inpatient in a secondary care hospital to three primary care facilities, resulting in 58 infections including 18 deaths in patients and 45 infections in healthcare workers (HCW). Only one of the deceased cases was fully v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hetemäki, Iivo, Kääriäinen, Sohvi, Alho, Pirjo, Mikkola, Janne, Savolainen-Kopra, Carita, Ikonen, Niina, Nohynek, Hanna, Lyytikäinen, Outi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2021
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323455/ https://www.ncbi.nlm.nih.gov/pubmed/34328076 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.30.2100636

Ejemplares similares

Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022
por: Lindh, Erika, et al.
Publicado: (2022)

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
por: Seppälä, Elina, et al.
Publicado: (2021)

A cluster of measles linked to an imported case, Finland, 2017
por: Seppälä, Elina, et al.
Publicado: (2017)

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020
por: Haveri, Anu, et al.
Publicado: (2020)

Highly pathogenic avian influenza A(H5N1) virus infection on multiple fur farms in the South and Central Ostrobothnia regions of Finland, July 2023
por: Lindh, Erika, et al.
Publicado: (2023)

Risk of COVID-19 in different groups of healthcare professionals between February 2020 and June 2021 in Finland: a register-based cohort study
por: Kääriäinen, Sohvi, et al.
Publicado: (2023)

Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
por: Lustig, Yaniv, et al.
Publicado: (2021)

Analysis of the Delta Variant B.1.617.2 COVID-19
por: Shiehzadegan, Shayan, et al.
Publicado: (2021)

Detection of SARS-CoV-2 Infection in Gargle, Spit, and Sputum Specimens
por: Poukka, Eero, et al.
Publicado: (2021)

Tap water as the source of a Legionnaires’ disease outbreak spread to several residential buildings and one hospital, Finland, 2020 to 2021
por: Mentula, Silja, et al.
Publicado: (2023)

Emergence of ceftazidime-avibactam-resistant Klebsiella pneumoniae during treatment, Finland, December 2018
por: Räisänen, Kati, et al.
Publicado: (2019)

Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022)

An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021
por: Williams, Sarah V, et al.
Publicado: (2021)

Clinical validation of automated and rapid mariPOC SARS-CoV-2 antigen test
por: Koskinen, Juha M., et al.
Publicado: (2021)

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021
por: Harder, Thomas, et al.
Publicado: (2021)

The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant
por: Cai, Changjing, et al.
Publicado: (2021)

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
por: Lopez Bernal, Jamie, et al.
Publicado: (2021)

Transmission of B.1.617.2 Delta variant between vaccinated healthcare workers
por: Kemp, Steven A., et al.
Publicado: (2022)

Genome Sequences of the Delta Variant (B.1.617.2) and the Kappa Variant (B.1.617.1) Detected in Morocco
por: Melloul, Marouane, et al.
Publicado: (2021)

Increasing severity of COVID-19 in pregnancy with Delta (B.1.617.2) variant surge
por: Adhikari, Emily H., et al.
Publicado: (2022)

Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
por: Arora, Prerna, et al.
Publicado: (2021)

Structural Evolution of Delta (B.1.617.2) and Omicron (BA.1) Spike Glycoproteins
por: Prandi, Ingrid Guarnetti, et al.
Publicado: (2022)

Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021
por: Lassaunière, Ria, et al.
Publicado: (2021)

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
por: Mlcochova, Petra, et al.
Publicado: (2021)

Chest CT features of children infected by B.1.617.2 (Delta) variant of COVID-19
por: Cheng, Qi-Rui, et al.
Publicado: (2021)

Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2
por: Li, Gun, et al.
Publicado: (2022)

Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2
por: Chun, June Young, et al.
Publicado: (2022)

Charge transport properties of SARS-CoV-2 Delta variant (B.1.617.2)
por: He, Lijun, et al.
Publicado: (2022)

Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets
por: Sun, Xiangjie, et al.
Publicado: (2023)

Chlamydia trachomatis samples testing falsely negative in the Aptima Combo 2 test in Finland, 2019
por: Rantakokko-Jalava, Kaisu, et al.
Publicado: (2019)

Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant
por: Rosato, Adriana E., et al.
Publicado: (2022)

Epidemiological analysis of SARS-COV-2 B.1.617.2 (delta variant) transmission in an educational institute
por: Vishnu Prasad, S., et al.
Publicado: (2022)

B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies
por: Zhan, Yan, et al.
Publicado: (2022)

Analysis of clinical characteristics of 66 pediatric patients with B.1.617.2 (Delta) variant of COVID-19
por: Hao, Jing, et al.
Publicado: (2022)

Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis
por: Mahumud, Rashidul Alam, et al.
Publicado: (2022)

SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
por: Lowry, Kym, et al.
Publicado: (2022)

Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds – a nationwide cohort study Finland, influenza season 2015/16
por: Nohynek, Hanna, et al.
Publicado: (2016)

Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections
por: Hetemäki, Iivo, et al.
Publicado: (2021)

Genetic emergence of B.1.617.2 in COVID-19
por: Kirola, L.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tctgblu6vecva6ns78foddivm5